Benn W Douglas

Avg. Two Year Performance

No purchase track record
(2%) Avg. Sale Return
(1%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(1%)< 1%(< 1%)(3%)(2%)
Sale Success Rate2 of 112 of 114 of 111 of 110 of 11
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 9.79K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--